Xtant Medical Holdings Inc. (XTNT)
$0.33
$-0.15
(-30.83%)
As on 11-Sep-2026 13:38EDT
Market cap
$56 Mln
Revenue (TTM)
$110 Mln
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.3 %
-
ROCE
-- %
-
Industry P/E
46.09
-
EV/EBITDA
5.6
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.1
-
Face value
--
-
Shares outstanding
140,287,960
10 Years Aggregate
CFO
$-45.72 Mln
EBITDA
$-26.90 Mln
Net Profit
$-183.60 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Xtant Medical Holdings (XTNT)
| -57.4 | -- | -- | -46.5 | -35.7 | -22.8 | -31.8 |
|
BSE Sensex
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Xtant Medical Holdings (XTNT)
| 76.1 | -60.5 | 71.2 | 17.9 | -53.2 | -25.2 | -0.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Xtant Medical Holdings (XTNT)
|
0.3 | 55.5 | 109.5 | -11.1 | -5.9 | -24.5 | -- | 1.4 |
| 68.7 | 8,162.7 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.0 | |
| 14.8 | 10,125.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.8 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.4 | |
| 53.7 | 8,913.0 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 168.7 | 10,637.8 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 15.3 | |
| 100.4 | 6,590.6 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.2 | 5.0 | |
| 85.8 | 5,350.1 | 1,579.2 | 145.6 | 14.3 | 8.9 | 36.9 | 3.2 | |
| 317.8 | 12,649.5 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.3 | 8.3 | |
| 165.7 | 9,458.6 | 785.1 | 41.5 | 9.9 | 2 | 232.8 | 4.6 |
Shareholding Pattern
View DetailsAbout Xtant Medical Holdings (XTNT)
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect... DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana. Read more
-
President, CEO & Director
Mr. Sean E. Browne
-
Vice President of Human Resources
Ms. Catherine Lundy
-
Headquarters
Belgrade, MT
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Xtant Medical Holdings (XTNT)
What is the current share price of Xtant Medical Holdings Inc (XTNT) Today?
The share price of Xtant Medical Holdings Inc (XTNT) is $0.33 (NYSE) as of 11-Sep-2026 13:38 EDT. Xtant Medical Holdings Inc (XTNT) has given a return of -35.72% in the last 3 years.
What is the current PB & PE ratio of Xtant Medical Holdings Inc (XTNT)?
Since, TTM earnings of Xtant Medical Holdings Inc (XTNT) is negative, P/E ratio is not available.
The P/B ratio of Xtant Medical Holdings Inc (XTNT) is 1.43 times as on 04-Sep-2026, a 62 discount to its peers’ median range of 3.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
23.60 |
2.30 |
2024 |
-3.74 |
1.43 |
2023 |
222.88 |
2.86 |
2022 |
-8.43 |
2.09 |
2021 |
-10.05 |
1.58 |
What is the 52 Week High and Low of Xtant Medical Holdings Inc (XTNT)?
The 52-week high and low of Xtant Medical Holdings Inc (XTNT) are Rs 0.95 and Rs 0.32 as of 12-Sep-2026.
What is the market cap of Xtant Medical Holdings Inc (XTNT)?
Xtant Medical Holdings Inc (XTNT) has a market capitalisation of $ 56 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Xtant Medical Holdings Inc (XTNT)?
Before investing in Xtant Medical Holdings Inc (XTNT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.